Edward Kowaloff

Internal Medicine physician in Cambridge, Massachusetts — also lists obesity medicine in the CMS registry.

Practice Details

Address
725 Concord Ave
Cambridge, MA 02138
Geocoded location: 42.3904, -71.1527
Taxonomy
Internal Medicine
Credential
M.D.
NPPES Enumeration
Listed with NPPES since 2005
Sole Proprietor
No
Provider Gender (NPPES)
Male
NPPES Record Updated
December 2012

Specialty taxonomies on file (2)

  • Internal Medicine
    Primary
  • Endocrinology
    Internal Medicine, Endocrinology, Diabetes & Metabolism

All specialty taxonomies this NPI reports in the CMS National Provider registry. A taxonomy on file reflects a self-reported designation, not confirmation of current services.

About This Clinician

Edward Kowaloff is an Internal Medicine physician in Cambridge whose NPPES record also lists an obesity-medicine or bariatric-medicine taxonomy as a secondary specialty. Primary-care and family-medicine clinicians who carry this secondary designation are among those most likely to actively manage GLP-1 prescribing, though this registry entry does not confirm current prescribing practices — call ahead to confirm.

Locally, this is 1 of 361 Internal Medicine practices in Cambridge carrying this exact taxonomy in our directory.

What to expect at an Internal Medicine visit

Internal-medicine practices manage adult and often complex chronic conditions. A GLP-1-related visit commonly involves:

  • •A review of chronic conditions, medications, and cardiovascular/metabolic risk.
  • •Baseline labs (A1c, metabolic panel, lipids) to guide treatment.
  • •A discussion of GLP-1 options for diabetes and/or weight management.
  • •A plan for follow-up monitoring and dose adjustment.

This is general guidance for internal medicine practices, not a description of Edward Kowaloff's specific protocol, services, or pricing. Confirm what a visit involves directly with the practice — 617-864-8822.

GLP-1 access in Cambridge, Massachusetts

Adult obesity rate
27.2%
#47 of 50 states (CDC BRFSS)
Avg. compounded semaglutide
$229/mo
Typical Massachusetts telehealth cash price
Medicaid GLP-1 coverage
Diabetes + obesity (with prior auth)
Massachusetts Medicaid, obesity indication

About 27.2% of Massachusetts adults have obesity (BMI 30+), ranking the state #47 of 50 (CDC BRFSS). Our directory currently lists 19 GLP-1-relevant clinics in Cambridge. If a cash-pay route makes more sense, compounded semaglutide through Massachusetts telehealth averages about $229/mo — well below brand-name Wegovy or Zepbound.

Explore more Massachusetts options on the best Massachusetts GLP-1 providers page, browse every Cambridge listing in the Cambridge clinic directory, or read the Massachusetts Medicaid GLP-1 coverage & prior-authorization guide.

Related Practices in Cambridge

Other Cambridge listings in the same directory tier:

William Kettyle
Internal Medicine

Telehealth Alternative

Prefer not to visit in person? Licensed GLP-1 telehealth providers ship compounded semaglutide or tirzepatide directly to Massachusetts addresses, often faster and at lower cash cost than an in-person visit and brand-name prescription. Featured Massachusetts telehealth partners:

Featured Partners · Cambridge

Featured GLP-1 providers serving Cambridge

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

  1. Top pick
    7.6
    Maximus

    Compounded from

    $249.99/mo

    Save $1,099.01/mo vs Wegovy
    Get started →
  2. 8.3
    Found

    Compounded from

    $99/mo

    Save $1,250/mo vs Wegovy
    Get started →
  3. 7.4
    Breeze Meds

    Compounded from

    $199/mo

    Save $1,150/mo vs Wegovy
    Get started →
  4. 6.2
    Wellorithm

    Compounded from

    $147/mo

    Save $1,202/mo vs Wegovy
    Get started →
  5. 8.2
    Gala

    Compounded from

    $149/mo

    Save $937/mo vs Zepbound
    Get started →
  6. 6.9
    TMates

    Compounded from

    $249/mo

    Save $1,100/mo vs Wegovy
    Get started →
See all 162 GLP-1 providers serving Cambridge ↓

See more Cambridge options on the Cambridge clinic directory, or compare the best semaglutide providers nationwide.

Learn more about the medications most commonly prescribed by Cambridge obesity-medicine and endocrinology practices: Semaglutide and Tirzepatide.

Frequently Asked Questions

The CMS National Provider registry lists Edward Kowaloff's specialty taxonomy but not the specific medications it prescribes or its current service menu. Edward Kowaloff is listed under Internal Medicine, a field where GLP-1 medications such as semaglutide (Wegovy, Ozempic) or tirzepatide (Zepbound, Mounjaro) are commonly prescribed — but whether this practice currently offers them isn't recorded in the registry. Call the practice at 617-864-8822 to confirm before booking.
According to its CMS National Provider registry (NPPES) record, Edward Kowaloff's primary specialty on file is Internal Medicine, with obesity medicine listed as a secondary taxonomy. Generalist clinicians who carry that secondary designation are among those who commonly manage GLP-1 prescribing, though the registry does not confirm current services.
Edward Kowaloff is located at 725 Concord Ave, Cambridge, MA 02138. The phone number listed in the registry is 617-864-8822. Its full record is public in the CMS National Provider registry under NPI 1437147071.
New-patient status isn't recorded in the CMS National Provider registry, so we can't confirm whether Edward Kowaloff is currently accepting new patients. Call the practice at 617-864-8822 to confirm availability, cash-pay pricing, and whether the services you need are offered — this listing reflects the NPPES taxonomy on file and is not an endorsement.